In Stock
Empagliflozin Tablets
Empagliflozin 25mg | Anti-Diabetic | Tablets
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic name: Empagliflozin Tablets 25 mg. Empagliflozin is an oral medicine in the sodium-glucose co-transporter 2 (SGLT2) inhibitor class. It is used for certain people with type 2 diabetes and, under specific approved indications, may also be used for heart failure or chronic kidney disease. This document is for general education only and does not replace the approved product leaflet or professional medical advice.
Product Introduction
Empagliflozin 25 mg tablets help the kidneys remove glucose from the body through urine by blocking the SGLT2 protein. In eligible patients, empagliflozin may be prescribed to improve blood-glucose control in type 2 diabetes. Depending on local approval and the patient’s condition, empagliflozin may also be used to reduce certain risks in people with heart failure or chronic kidney disease. It is used as part of an individualized care plan that may include diet, physical activity and other medicines.
1. Uses
Used with diet and physical activity to improve blood-glucose control in adults with type 2 diabetes, when appropriate under the local product label.
May be prescribed for certain adults with heart failure or chronic kidney disease to reduce specified adverse outcomes, according to approved indications.
In some settings, it is used to reduce cardiovascular risk in eligible adults with type 2 diabetes and established cardiovascular disease.
It is not a routine treatment for type 1 diabetes because it can increase the risk of diabetic ketoacidosis. It is not a treatment for diabetic ketoacidosis.
2. Benefits
Can help lower blood glucose in eligible people with type 2 diabetes by increasing glucose excretion in urine.
In selected patients, it may reduce the risk of hospitalization for heart failure and other outcomes covered by the approved indication.
May help slow progression of chronic kidney disease in eligible patients, according to clinical evidence and approved local use.
May lead to modest weight loss and a small reduction in blood pressure in some people; individual effects vary.
Benefits depend on the person’s diagnosis, kidney function, other medicines and overall care plan. Empagliflozin is not a substitute for prescribed diabetes, heart or kidney treatment.
3. Side Effects
Possible side effects include:
Genital yeast/fungal infections, such as itching, redness or discharge.
Increased urination and fluid loss, which may cause thirst, dizziness or light-headedness.
Urinary tract infections.
Low blood sugar, especially when combined with insulin or a sulfonylurea.
Rare but serious: diabetic ketoacidosis (which may occur even if blood glucose is not very high), severe genital/perineal infections, or severe allergic reactions.
Seek urgent medical care for nausea or vomiting, abdominal pain, unusual tiredness, rapid/deep breathing, confusion or fruity-smelling breath, which may indicate ketoacidosis. Seek urgent care for fever with back/side pain, severe genital/perineal pain or swelling, or facial/throat swelling or difficulty breathing.
4. Safety Advice
Take only as prescribed. Do not start, stop or change the dose without consulting your clinician.
Tell your clinician if you have kidney or liver disease, low blood pressure, recurrent urinary/genital infections, or a history of diabetic ketoacidosis.
Maintain fluid intake as advised, unless your clinician has restricted fluids. Seek advice if you have vomiting, diarrhoea, fever or cannot keep fluids down.
Your clinician may advise temporarily withholding empagliflozin during significant acute illness, prolonged fasting or before major surgery because of ketoacidosis risk. Follow your specific sick-day instructions.
Tell your clinician before surgery or medical procedures and before starting a very-low-carbohydrate or ketogenic diet.
If you take insulin or a sulfonylurea, low blood sugar may be more likely and doses may need clinical review.
Tell your healthcare professional if you are pregnant, planning pregnancy or breastfeeding. It may not be suitable during pregnancy; seek professional advice.
Monitor blood glucose and kidney function as advised. Suitability may depend on kidney function and the reason for treatment.
Seek prompt care for symptoms of ketoacidosis, severe infection, dehydration or a serious allergic reaction.
Keep out of reach of children and store according to the package instructions.
5. How It Works
Empagliflozin blocks the SGLT2 protein in the kidneys, reducing reabsorption of filtered glucose and allowing more glucose to leave the body in urine. This lowers blood glucose and has a mild diuretic effect. Its benefits for heart failure and kidney disease in eligible patients are not explained solely by glucose lowering. Increased urinary glucose can raise the risk of genital fungal infections and fluid loss.
6. How to Use
Follow the prescription label and patient leaflet supplied with your exact product.
Empagliflozin is commonly taken once daily, with or without food. The 25 mg strength may be prescribed for additional glucose control in appropriate patients; follow your clinician’s exact instructions and local label.
Swallow the tablet with water.
Do not take more than prescribed. The appropriate dose depends on the indication, kidney function and other medical factors.
If you miss a dose, follow the package leaflet or ask a pharmacist. Do not take a double dose to make up for a missed dose.
If you take more than prescribed or suspect an overdose, seek prompt medical advice.
Follow your clinician’s sick-day plan and instructions about temporarily withholding the medicine before surgery or during acute illness.
7. Quick Tips
Take the tablet consistently at the prescribed time each day.
Maintain fluid intake as advised and stand up slowly if you feel dizzy.
Know the warning signs of ketoacidosis; it can occur even without very high blood glucose.
Seek advice early for genital itching/discharge, painful urination, fever or symptoms of dehydration.
Tell every healthcare professional that you take empagliflozin, especially before surgery or during acute illness.
Monitor blood glucose and kidney function according to your care plan.
Do not share your medicine and do not stop other diabetes, heart or kidney medicines without professional advice.
8. Drug Interactions
Tell your doctor and pharmacist about all prescription medicines, over-the-counter products, vitamins and herbal supplements. Interactions may affect blood glucose, fluid balance or the risk of adverse effects.
Insulin and sulfonylureas (such as glimepiride or gliclazide): may increase the risk of hypoglycaemia; the prescriber may consider adjusting their doses.
Diuretics (water tablets): may increase urine output, dehydration or low blood pressure.
Lithium: empagliflozin may affect lithium levels; monitoring may be needed.
Medicines affecting kidney function or blood pressure may require clinical review, particularly if dehydration or low blood pressure occurs.
Other glucose-lowering medicines: combinations may be appropriate but should be directed and monitored by a clinician.
Do not start, stop or change any medicine without professional advice.
| Product Name | Empagliflozin Tablets |
| Category | All Medicines, Anti Diabetic |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 25mg |
|---|---|
| Type | Single API |
| Form | Tablets |
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
